HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home

AI/ML (661)

6:57

Mount Sinai, ARC, NVIDIA tackle human genome

Leaders from Mount Sinai Health System, ARC Innovation Center and NVIDIA discuss their partnership to leverage AI and vast datasets to unlock insights into the human genome to better understand how patients may respond to therapies.

Mount Sinai, ARC, NVIDIA tackle human genome
Leaders from Mount Sinai Health System, ARC Innovation Center and NVIDIA discuss their partnership to leverage AI and vast datasets to unlock insights into the human genome to better understand how patients may respond to therapies.
6:57
14:51

HIMSS26: What ASTP/ONC has planned for the show, and the year ahead

Dr. Thomas Keane, assistant secretary for technology policy and national coordinator for health IT, describes his plans for the conference and talks about TEFCA, HTI-4, HTI-5, imaging data, behavioral health exchange and more.

HIMSS26: What ASTP/ONC has planned for the show, and the year ahead
Dr. Thomas Keane, assistant secretary for technology policy and national coordinator for health IT, describes his plans for the conference and talks about TEFCA, HTI-4, HTI-5, imaging data, behavioral health exchange and more.
14:51
15:24

CEO Hal Wolf offers a preview of the HIMSS Global Health Conference & Exhibition

As health systems around the world grapple with an array of pressing challenges, it's time to "skate where the puck is going to be." In Las Vegas from March 9-12, IT leaders can help point the way forward for AI-powered digital transformation.

CEO Hal Wolf offers a preview of the HIMSS Global Health Conference & Exhibition
As health systems around the world grapple with an array of pressing challenges, it's time to "skate where the puck is going to be." In Las Vegas from March 9-12, IT leaders can help point the way forward for AI-powered digital transformation.
15:24
10:16

CIO Spotlight: Cleveland Clinic's Sarah Hatchett

She offers updates on some key IT initiatives for 2026 at the world-renowned health system, from AI to quantum computing. She also gives a sneak-peak of her presentation at HIMSS26, where she'll be discussing smart hospital design.

CIO Spotlight: Cleveland Clinic's Sarah Hatchett
She offers updates on some key IT initiatives for 2026 at the world-renowned health system, from AI to quantum computing. She also gives a sneak-peak of her presentation at HIMSS26, where she'll be discussing smart hospital design.
10:16
3:59

Dogs and AI help detect cancer through breath

Shlomi Madar, CEO of SpotitEarly, discusses how the company helps detect cancer by leveraging dogs’ sense of smell, AI technology and reward-based training that teaches dogs to distinguish between healthy and cancerous samples.

Dogs and AI help detect cancer through breath
Shlomi Madar, CEO of SpotitEarly, discusses how the company helps detect cancer by leveraging dogs’ sense of smell, AI technology and reward-based training that teaches dogs to distinguish between healthy and cancerous samples.
3:59
4:28

The model context protocol at work in AI and clinical workflows

Virginia Halsey, senior vice president of strategy and product management at FDB, discusses the MCP standard and how it can scale AI safely in clinical workflows and unlock safe automation across medication workflows.

The model context protocol at work in AI and clinical workflows
Virginia Halsey, senior vice president of strategy and product management at FDB, discusses the MCP standard and how it can scale AI safely in clinical workflows and unlock safe automation across medication workflows.
4:28
2:59

Innovaccer founder talks failure, growth at HIMSS26

Abhinav Shashank, Innovaccer CEO and cofounder, discusses the company's manifesto, Autonomous Healthcare, and previews the HIMSS26 panel where he'll join other unicorn founders to share stories of their origins, failures and breakthroughs.

Innovaccer founder talks failure, growth at HIMSS26
Abhinav Shashank, Innovaccer CEO and cofounder, discusses the company's manifesto, Autonomous Healthcare, and previews the HIMSS26 panel where he'll join other unicorn founders to share stories of their origins, failures and breakthroughs.
2:59
6:26

Lirio blends behavioral science and AI personalization

Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.

Lirio blends behavioral science and AI personalization
Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.
6:26
12:08

Best practice for keeping tabs on AI hygiene

Practice management requires a human in the loop for the use of artificial intelligence, as well as a "human on the loop" that assures the quality of AI agents handling automated processes, says Michael Clark, Onpoint Healthcare Partners president.

Best practice for keeping tabs on AI hygiene
Practice management requires a human in the loop for the use of artificial intelligence, as well as a "human on the loop" that assures the quality of AI agents handling automated processes, says Michael Clark, Onpoint Healthcare Partners president.
12:08
4:40

AION Labs to explore quantum tech

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

AION Labs to explore quantum tech
Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.
4:40
9:56

CIO Spotlight: Artesia General Hospital's Eric Jimenez

The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

CIO Spotlight: Artesia General Hospital's Eric Jimenez
The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.
9:56
6:41

The need to move AI regulation faster

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The need to move AI regulation faster
The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.
6:41
of 56
Play video Mount Sinai, ARC, NVIDIA tackle human genome
AI/ML
Mount Sinai, ARC, NVIDIA tackle human genome
Play video HIMSS26: What ASTP/ONC has planned for the show, and the year ahead
AI/ML
HIMSS26: What ASTP/ONC has planned for the show, and the year ahead
Play video CEO Hal Wolf offers a preview of the HIMSS Global Health Conference & Exhibition
AI/ML
CEO Hal Wolf offers a preview of the HIMSS Global Health Conference & Exhibition
Play video CIO Spotlight: Cleveland Clinic's Sarah Hatchett
AI/ML
CIO Spotlight: Cleveland Clinic's Sarah Hatchett

View more in AI/ML (661 videos)

3:59

Dogs and AI help detect cancer through breath

Shlomi Madar, CEO of SpotitEarly, discusses how the company helps detect cancer by leveraging dogs’ sense of smell, AI technology and reward-based training that teaches dogs to distinguish between healthy and cancerous samples.

Dogs and AI help detect cancer through breath
Shlomi Madar, CEO of SpotitEarly, discusses how the company helps detect cancer by leveraging dogs’ sense of smell, AI technology and reward-based training that teaches dogs to distinguish between healthy and cancerous samples.
3:59
4:28

The model context protocol at work in AI and clinical workflows

Virginia Halsey, senior vice president of strategy and product management at FDB, discusses the MCP standard and how it can scale AI safely in clinical workflows and unlock safe automation across medication workflows.

The model context protocol at work in AI and clinical workflows
Virginia Halsey, senior vice president of strategy and product management at FDB, discusses the MCP standard and how it can scale AI safely in clinical workflows and unlock safe automation across medication workflows.
4:28
2:59

Innovaccer founder talks failure, growth at HIMSS26

Abhinav Shashank, Innovaccer CEO and cofounder, discusses the company's manifesto, Autonomous Healthcare, and previews the HIMSS26 panel where he'll join other unicorn founders to share stories of their origins, failures and breakthroughs.

Innovaccer founder talks failure, growth at HIMSS26
Abhinav Shashank, Innovaccer CEO and cofounder, discusses the company's manifesto, Autonomous Healthcare, and previews the HIMSS26 panel where he'll join other unicorn founders to share stories of their origins, failures and breakthroughs.
2:59
6:26

Lirio blends behavioral science and AI personalization

Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.

Lirio blends behavioral science and AI personalization
Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.
6:26
12:08

Best practice for keeping tabs on AI hygiene

Practice management requires a human in the loop for the use of artificial intelligence, as well as a "human on the loop" that assures the quality of AI agents handling automated processes, says Michael Clark, Onpoint Healthcare Partners president.

Best practice for keeping tabs on AI hygiene
Practice management requires a human in the loop for the use of artificial intelligence, as well as a "human on the loop" that assures the quality of AI agents handling automated processes, says Michael Clark, Onpoint Healthcare Partners president.
12:08
4:40

AION Labs to explore quantum tech

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

AION Labs to explore quantum tech
Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.
4:40
9:56

CIO Spotlight: Artesia General Hospital's Eric Jimenez

The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

CIO Spotlight: Artesia General Hospital's Eric Jimenez
The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.
9:56
6:41

The need to move AI regulation faster

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The need to move AI regulation faster
The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.
6:41